https://www.selleckchem.com/products/AZD0530.html
970. The signature was further validated in an internal validation cohort and an integrated external cohort (Zhengzhou and Anyang cohorts) with AUCs of 0.890 and 0.859, respectively. Importantly, a multivariate analysis showed that the signature was the only independent predictor for pCR. In addition, patients with high predictive scores showed significantly longer overall and relapse-free survival across multiple centers (P less then 0.05). This is the first, validated, and clinically applicable individualized immune signature of pCR
Like
Comment
Share
